Anti-inflammatory effects of granulocyte colony-stimulating factor

Current Opinion in Hematology

Volumn 5, Issue 3, 1998, Pages 221-225

  Hartung, Thomas ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

BLOOD LEVEL; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; TISSUE INJURY;

EID: 0031876655     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199805000-00013     Document Type: Review

References (33)

1. Smith JA: Neutrophils, host defense, and inflammation: a double-edged sword. J Leuk Biol 1994, 56:672-686.
2. Cebon J, Layton JE, Maher D, Morstyn G: Endogenous haematopoetic growth factors in neutropenia and infection. Br J Haematol 1994, 86:265-274.
3. Tanaka H, Ishikawa K, Nishino M, Shimazu T, Yoshioka T: Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma 1996, 40:718-726.
4. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994, 84:1737-1746.
5. Nelson S: Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the nonneutropenic host: an overview. Clin Infect Dis 1994, 18(suppl 2):S197-204.
6. Barsig J, Bundschuh DS, Hartung T, Bauhofer A, Sauer A, Wendel A: Control of fecal peritoneal infection in mice by colony-stimulating factors. J Infect Dis 1996, 174:790-799.
7. Demetri GD, Griffin JD: Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78:2791-2808.
8. Dale DC, Liles WC, Summer WR, Nelson S: Granulocyte colony-stimulating factor: role and relationship in infectious diseases. J Infect Dis 1995, 172:1061-1075.
9. Hartung T, Wendel A: Immunomodulatory properties of filgrastim (r-metHuG-CSF) in preclinical models. Edited by G. Morstyn, et al. In Filgrastim (r-metHuG-CSF) in clinical practice. Marcel Dekker. New York: 1998; 397-427.
10. Dale D: Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases. Clin Infect Dis 1994, 18(suppl 2):S197-204.
11. Görgen I, Hartung T, Leist M, Niehörster M, Tiegs G, Uhlig S, Weitzel F, Wendel A: Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-lnduced toxicity via suppression of systemic tumor necrosis factor-α. J Immunol 1992, 149:918-924.
12. Terashima T, Soejima K, Waki Y, Nakamura H, Fujishima S, Suzuki Y, Ishizaka A, Kanzawa M: Neutrophils activated by granulocyte colony-stimulating factor suppress tumor necrosis factor-α release from monocytes stimulated by endotoxin. Am J Respir Cell Mol Biol 1995, 13:69-73.
13. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, Miura AB: Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-a production. Blood 1995, 86:2220-2227.
14. Aoki Y, Hiromatsu K, Kobayashi N, Hotta T, Saito H, Igarashi H, Niho Y, Yoshikai Y: Protective effect of granulocyte colony-stimulating factor against T-cell-mediated lethal shock triggered by superantigens. Blood 1995, 86:1420-1427.
15. Pan L, Delmonte J, Jalonen CK, Ferrara JLM: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995, 86:4422-4429.
16. Chang JM, Metcalf D, Gonda TJ, Johnson GR: Long-term exposure to retrovirally expressed granulocyte-colony-stimulatlng factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. J Clin Invest 1989, 84:1488-1496.
17. Vollmar B, Messner S, Wanner GA, Hartung T, Menger MD: Immunomodulatory action of granulocyte-colony-stimulating factor in a rat model of endotoxin-induced liver injury: a intravital microscopic analysis of Kupffer cell and leukocyte response. J Leuk Biol 1997, 62:710-718.
18. Kanazawa M, Ishizaka A, Hasegawa N, Suzuki Y, Yokoyama T: Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1988, 148:1030-1035.
19. Fink MP, O'Sullivan BP, Menconi MJ, Wollert SP, Wang H, Youssef ME, Belleisle JM: Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 1993, 34:571-578.
20. Eichacker PQ, Waisman Y, Natanson C, Farese A, Hoffmann WD, Banks SM, MacVittie TJ: Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 1994, 77:2366-2373.
21. Lorenz W, Reimund KP, Weitzel F, Celik I, Kurnatowski M, Schneider C, Mannheim W, Heiske A, Neumann K, Sitter H: Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 1994, 116:925-934.
22. Lundblad R, Nesland JM, Giercksky K-E: Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intraabdominal sepsis in rats. Crit Care Med 1996, 24:820-826.
23. Hartung T, Döcke W-D, Gantner F, Krieger G, Sauer A, Stevens P, Volk H-D, Wendel A: Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995, 85:2482-2489.
24. Hartung T, Volk H-D, Wendel A: G-CSF: an anti-inflammatory cytokine. J Endotoxin Res 1995, 2:195-201.
25. Pajkrt D, Manten A, van der Poll T, Tiel-van Buul MM, Jansen J, Wouter ten Cate J, van Deventer SJ: Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 1997, 90:1415-1424. This paper extends the previous ex vivo findings regarding the anti inflammatory effect of G-CSF treatment to the in vivo situation of human volunteers challenged with endotoxin.
26. Denzlinger C, Holler E, Reisbach G, Hiller E, Wilmanns W: Granulocyte colony-stimulating factor inhibits the endogenous leukotriene production in tumor patients. Br J Haematol 1994, 86:881-882.
27. Andresen J, Movahhed H, Nelson S: Filgrastim (r-metHuG-CSF) in pneumonia in: G. Morstyn et al., Filgrastim (r-metHuG-CSF) in clinical practice, Dekker, New York, 1998, 429-446.
28. Foster PF, Mital D, Sankary HN, McChesney LP, Marcon JM, Koukoulis G, Kociss K, Leurgans S, Whiting JF, Williams JW: The use of granulocyte colony-stimulating factor after liver transplantation. Transplantation 1995, 59:1557-1563.
29. Endo S, Inada K, Inoue Y, Yamada Y, Takakuwa T, Kasai T, Nakae H, Kuwata Y, Hoshi S, Yashida M: Evaluation of recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy in granulopoetic patients complicated with sepsis. Curr Med Res Opin 1994, 13:233-241.
30. Weiss M, Gross-Weege W, Schneider M, Neidhardt H, Uebert S, Mirow N, Wemet P: Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. J Crit Care 1995, 10:21-26.
31. Tiegs G, Barsig J, Matiba B, Uhlig S, Wendel A: Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest 1994, 93:2616-2622.
32. Bundschuh DS, Barsig J, Hartung T, Randow F, Döcke W-D, Volk H D, Wendel A: Granulocyte-macrophage colony-stimulating factor and IFN-γ restore the systemic TNF-α response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol 1997, 158:2862-2871.
33. Wiltschke C, Krainer M, Wagner A, Linkesch W, Zielinski CC: Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity. Exp Hematol 1995, 23:402-406.